Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe*, Johan Askling, Adrian Ciurea, Herman Mann, Fatos Onen, Eirik Klami Kristianslund, Dan Nordström, Maria Jose Santos, Catalin Codreanu, Juan Gómez-Reino, Ziga Rotar, Bjorn Gudbjornsson, Daniela Di Giuseppe, Michael J. Nissen, Karel Pavelka, Merih Birlik, Tore Kvien, Kari Kalervo Eklund, Anabela BarcelosRuxandra Ionescu, Carlos Sanchez-Piedra, Matija Tomsic, Árni Jón Geirsson, Anne Gitte Loft, Irene Van Der Horst-Bruinsma, Gareth Jones, Florenzo Iannone, Lise Hyldstrup, Niels Steen Krogh, Merete Lund Hetland, Mikkel Østergaard

*Corresponding author for this work
11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds